Bicocca Open Archive

Logo unimib boa
TODDE, SERGIO CAMILLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.542
AS - Asia 5.440
EU - Europa 4.197
SA - Sud America 634
AF - Africa 120
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.950
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.106
VN - Vietnam 1.645
SG - Singapore 1.400
IT - Italia 1.070
CN - Cina 1.031
DE - Germania 673
HK - Hong Kong 538
RU - Federazione Russa 500
SE - Svezia 488
BR - Brasile 471
CA - Canada 367
IE - Irlanda 306
GB - Regno Unito 242
UA - Ucraina 239
FR - Francia 159
BD - Bangladesh 151
FI - Finlandia 149
IN - India 147
KR - Corea 87
AT - Austria 85
ID - Indonesia 68
AR - Argentina 63
TR - Turchia 54
IQ - Iraq 52
NL - Olanda 52
ZA - Sudafrica 46
PK - Pakistan 40
JP - Giappone 39
PL - Polonia 39
ES - Italia 37
DK - Danimarca 36
SA - Arabia Saudita 35
MX - Messico 32
EC - Ecuador 28
PH - Filippine 27
CO - Colombia 23
BE - Belgio 22
MA - Marocco 17
CH - Svizzera 15
IR - Iran 15
MY - Malesia 15
CZ - Repubblica Ceca 14
BG - Bulgaria 13
UZ - Uzbekistan 13
KE - Kenya 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
RO - Romania 10
TN - Tunisia 10
PE - Perù 9
JM - Giamaica 8
PT - Portogallo 8
DO - Repubblica Dominicana 7
EG - Egitto 7
KZ - Kazakistan 7
PY - Paraguay 7
TH - Thailandia 7
AU - Australia 6
GR - Grecia 6
JO - Giordania 6
LT - Lituania 6
NP - Nepal 6
OM - Oman 6
SK - Slovacchia (Repubblica Slovacca) 6
AZ - Azerbaigian 5
BO - Bolivia 5
DZ - Algeria 5
EU - Europa 5
HN - Honduras 5
LB - Libano 5
TW - Taiwan 5
CR - Costa Rica 4
ET - Etiopia 4
LV - Lettonia 4
MK - Macedonia 4
NG - Nigeria 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SN - Senegal 4
AO - Angola 3
IL - Israele 3
KG - Kirghizistan 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
NI - Nicaragua 3
PA - Panama 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
LY - Libia 2
ME - Montenegro 2
MN - Mongolia 2
PS - Palestinian Territory 2
QA - Qatar 2
RE - Reunion 2
Totale 18.934
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.568
Ashburn 854
Singapore 805
Hong Kong 513
Ho Chi Minh City 510
Hanoi 455
San Jose 438
Fairfield 433
Houston 391
Woodbridge 359
Wilmington 332
Chandler 321
Dublin 288
Milan 273
Jacksonville 247
Toronto 243
New York 234
Frankfurt am Main 207
Dearborn 194
Santa Clara 187
Seattle 173
Los Angeles 162
Beijing 161
Dallas 147
Hefei 136
Cambridge 135
Chicago 121
Munich 121
Princeton 114
The Dalles 98
Nanjing 83
Rome 83
Seoul 77
Helsinki 72
Vienna 67
Council Bluffs 64
Lauterbourg 62
Da Nang 61
Shanghai 60
Altamura 59
Boardman 56
São Paulo 53
Buffalo 49
Lawrence 49
Haiphong 48
Jakarta 46
Moscow 41
Lachine 39
San Diego 37
Orem 35
Ninh Bình 33
Quận Bình Thạnh 31
Turin 31
Biên Hòa 30
Tokyo 29
Guangzhou 27
Ha Long 27
Hải Dương 27
Shenyang 27
Warsaw 25
Changsha 24
Denver 24
London 24
Nürnberg 24
Thái Nguyên 24
Hebei 23
Can Tho 22
Tianjin 22
Brussels 21
Lissone 21
Dhaka 20
Nanchang 20
Falls Church 19
Montreal 19
Turku 19
Andover 18
Chennai 17
Dong Ket 17
Jinan 17
Phoenix 17
Stockholm 17
Atlanta 16
Baghdad 16
Bologna 16
Brooklyn 16
Fremont 16
Genoa 16
Jiaxing 16
Ottawa 16
Salt Lake City 16
Bắc Ninh 15
Jeddah 15
Montréal 15
Naples 15
Rio de Janeiro 15
Amsterdam 14
Columbus 14
Johannesburg 14
Quận Một 13
Vinh 13
Totale 12.364
Salva come PNG Salva come JPEG
Nome #
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player 801
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 566
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 537
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 529
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study 522
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 464
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 455
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 453
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 421
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 410
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 410
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 379
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 365
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 364
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 345
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 329
Highlight selection of radiochemistry and radiopharmacy developments by editorial board 317
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 314
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 310
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies 310
PET imaging and single-cell RNA sequencing glioma microenvironment assessment after RT combined therapy 308
PET radiopharmacy and automation 307
Sperimentazione clinica con radiofarmaci 297
EANM Guideline on the validation of analytical methods for radiopharmaceuticals 290
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 283
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework 280
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 280
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 271
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 267
Quality Control in the Production of Radiopharmaceuticals 267
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 263
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 263
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 262
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 260
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 260
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 259
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 255
Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons 254
Rsdiofarmaci marcati con fluoro-18 254
Produzione e verifiche di qualità dei radiofarmaci estemporanei per PET e terapia 252
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 247
European regulations for the introduction of novel radiopharmaceuticals in the clinical setting 247
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 243
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 242
Preparation of [11C]radioligands with high specific radioactivity on a commercial PET tracer synthesizer 240
Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals 238
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 233
Automation of [C-11]acyl chloride syntheses using commercially available C-11-modules 233
High yield synthesis of [11C]-acetone through selective quenching of methyl lithium 226
Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility 223
Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time 214
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 200
Guidance on validation and qualification of processes and operations involving radiopharmaceuticals 193
PET in psychopharmacology 192
Synthesis of [O-methyl-11c]fluvoxamine-a potential serotonin uptake site radioligand 191
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A2A receptor system using positron emission tomography [2] 185
EANM guideline on quality risk management for radiopharmaceuticals 184
Classificazione ambientale 179
From radiotracer to radiopharmaceutical: a philosophical approach 177
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals 167
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken' 160
Highlight selection of radiochemistry and radiopharmacy developments by editorial board 154
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals 153
A PET follow-up study of recovery after stroke in acute aphasics 151
Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: A European perspective 151
Mild synthesis of [N-methyl-11C]-isovaleroyl-(L)-carnitine. The usefulness of a tritium approach. 139
Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging 119
Application of molecular imaging as potential prognostic biomarker for triple-negative breast cancer (TNBC) 39
Totale 19.353
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.296
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.021 89 111 168 136 35 59 62 69 49 59 77 107
2022/20231.344 164 387 84 134 100 197 26 78 71 19 57 27
2023/20241.109 44 40 56 39 147 310 211 40 85 12 8 117
2024/20252.572 137 251 120 98 217 179 202 158 239 341 207 423
2025/20267.840 1.558 742 508 736 704 356 913 311 510 535 464 503
Totale 19.353